1

Retasturtide: A Novel GLP-1 Receptor Agonist for Type 2 Diabetes

News Discuss 
Retasturtide is a recently introduced novel drug demonstrating promising results in the management of type 2 diabetes. This synthetic peptide mimics the actions of naturally present GLP-1, a hormone that plays a https://getsocialsource.com/story6277087/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story